Resumo
Background: Changes in purinergic and cholinergic signaling have been demonstrated in various pathologies associatedwith inflammation; however, the changes in brucellosis caused by the Gram-negative coccobacillus Brucella ovis are notknown. B. ovis is generally asymptomatic in ewes. Hepatosplenomegaly has been described in B. ovis, a non-zoonoticspecies, characterized by an extravascular inflammatory response. Purinergic system enzymes are closely involved withthe modulation of the immune system, pro- and anti-inflammatory events. The objective of this study was to investigatethe role of ectonucleotidases and cholinesterases in the brains of mice experimentally infected with B. ovis.Materials, Methods & Results: Forty-eight animals were divided into two groups: control (n = 24) and infected (n = 24).In group infected, 100 µL containing 1.3 x 107 UFC B. ovis /mL via intraperitoneal was used in inoculation. The brainswere collected from the animals on days 7, 15, 30 and 60 post-infection (PI). We measured levels of TBARS (substancesreactive to thiobarbituric acid) and ROS (reactive oxygen species) in the brain. The activity of NTPDase (using ATP andADP as substrate) and 5-nucleotidase (using AMP as substrate) were evaluated in brain in addition to histopathologicalanalysis. No histopathological lesions were observed in the control group nor the infected group at days 7, 15, and 30 PI.However, multifocal areas with moderate microgliosis in the cerebral cortex were observed at day 60 PI in the infectedanimals. B. ovis DNA was detected in brain. During the course of infection, B. ovis caused greater lipid peroxidation inthe brains of infected animals than in the control group at day 60 PI. No significant results were observed at 7, 15 or day30 PI. Similarly, there was significantly more reactive oxygen species at day 60 PI in brains of infected animals than inthe control group. NTPDase activity (using ATP ...
Assuntos
Animais , Camundongos , /análise , Acetilcolinesterase/análise , Brucella ovis/química , Estresse Oxidativo , Purinérgicos , Trifosfato de AdenosinaResumo
Background: Changes in purinergic and cholinergic signaling have been demonstrated in various pathologies associatedwith inflammation; however, the changes in brucellosis caused by the Gram-negative coccobacillus Brucella ovis are notknown. B. ovis is generally asymptomatic in ewes. Hepatosplenomegaly has been described in B. ovis, a non-zoonoticspecies, characterized by an extravascular inflammatory response. Purinergic system enzymes are closely involved withthe modulation of the immune system, pro- and anti-inflammatory events. The objective of this study was to investigatethe role of ectonucleotidases and cholinesterases in the brains of mice experimentally infected with B. ovis.Materials, Methods & Results: Forty-eight animals were divided into two groups: control (n = 24) and infected (n = 24).In group infected, 100 µL containing 1.3 x 107 UFC B. ovis /mL via intraperitoneal was used in inoculation. The brainswere collected from the animals on days 7, 15, 30 and 60 post-infection (PI). We measured levels of TBARS (substancesreactive to thiobarbituric acid) and ROS (reactive oxygen species) in the brain. The activity of NTPDase (using ATP andADP as substrate) and 5-nucleotidase (using AMP as substrate) were evaluated in brain in addition to histopathologicalanalysis. No histopathological lesions were observed in the control group nor the infected group at days 7, 15, and 30 PI.However, multifocal areas with moderate microgliosis in the cerebral cortex were observed at day 60 PI in the infectedanimals. B. ovis DNA was detected in brain. During the course of infection, B. ovis caused greater lipid peroxidation inthe brains of infected animals than in the control group at day 60 PI. No significant results were observed at 7, 15 or day30 PI. Similarly, there was significantly more reactive oxygen species at day 60 PI in brains of infected animals than inthe control group. NTPDase activity (using ATP ...(AU)
Assuntos
Animais , Camundongos , Brucella ovis/química , 5'-Nucleotidase/análise , Estresse Oxidativo , Acetilcolinesterase/análise , Purinérgicos , Trifosfato de AdenosinaResumo
Background: Curcumin, a polyphenol derived from rhizome of Curcuma longa, has been successfully used in animals and humans due to its antibacterial and anti-inflammatory properties. Recently, a study demonstrated that curcumin ointment reduced pain, mammary tension and erythema in humans with mastitis 72 h after the treatment. Mastitis in sheep is an important problem due to restrictions associated to the use of antibiotics, affecting milk production and becoming a public health issue. Thus, the aim of this study was to verify whether the addition of curcumin in the diet of six female sheep with subclinical mastitis could have curative efficacy and benefits to animal health.Cases: Six Lacaune sheep with subclinical mastitis that persisted for more than thirty days after the parturition were used. The animals received feed containing the curcumin (60 mg/animal/day) during 10 days. On days 0 and 10 of the experiment, total blood was collected to perform the hemogram and serum biochemistry (triglycerides, cholesterol, glucose, total protein (TP), albumin, globulin, aspartate aminotransferase (AST) and urea), as well as individual milk samples for centesimal composition, somatic cell count (SCC) and total bacterial count (TBC). Total leukocytes and erythrocytes, as well as hemoglobin content, were obtained using the hematological counter CELM-CC-550. Blood smears were stained by the Romanowsky method and used for leukocytes differentiation. After ten days of treatment, five sheep were negative in the California Mastitis Test (CMT). Total erythrocytes increased, while total leukocytes decreased after the treatment. Seric levels of AST, triglycerides, cholesterol and globulins decreased, while seric levels of albumin and urea increased after ten days of treatment. No differences were observed regarding milk production and composition, as well as for SCC and TBC on days 0 and 10 post-treatment.[...]
Assuntos
Feminino , Animais , Aditivos Alimentares/uso terapêutico , Curcumina/uso terapêutico , Mastite/terapia , Mastite/veterinária , OvinosResumo
Background: Curcumin, a polyphenol derived from rhizome of Curcuma longa, has been successfully used in animals and humans due to its antibacterial and anti-inflammatory properties. Recently, a study demonstrated that curcumin ointment reduced pain, mammary tension and erythema in humans with mastitis 72 h after the treatment. Mastitis in sheep is an important problem due to restrictions associated to the use of antibiotics, affecting milk production and becoming a public health issue. Thus, the aim of this study was to verify whether the addition of curcumin in the diet of six female sheep with subclinical mastitis could have curative efficacy and benefits to animal health.Cases: Six Lacaune sheep with subclinical mastitis that persisted for more than thirty days after the parturition were used. The animals received feed containing the curcumin (60 mg/animal/day) during 10 days. On days 0 and 10 of the experiment, total blood was collected to perform the hemogram and serum biochemistry (triglycerides, cholesterol, glucose, total protein (TP), albumin, globulin, aspartate aminotransferase (AST) and urea), as well as individual milk samples for centesimal composition, somatic cell count (SCC) and total bacterial count (TBC). Total leukocytes and erythrocytes, as well as hemoglobin content, were obtained using the hematological counter CELM-CC-550. Blood smears were stained by the Romanowsky method and used for leukocytes differentiation. After ten days of treatment, five sheep were negative in the California Mastitis Test (CMT). Total erythrocytes increased, while total leukocytes decreased after the treatment. Seric levels of AST, triglycerides, cholesterol and globulins decreased, while seric levels of albumin and urea increased after ten days of treatment. No differences were observed regarding milk production and composition, as well as for SCC and TBC on days 0 and 10 post-treatment.[...](AU)